<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7565683" created="25/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7565683</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="N-_and_C-terminal_sequence" sem="Protein_domain_or_region"><term id="A20" sem="Protein_domain_or_region">N-</term> and <term id="A22" sem="Protein_domain_or_region"><term id="A21" sem="Protein_domain_or_region">C-</term>terminal sequences</term></term> control degradation of <term id="T2" lex="MAD3/I_kappa_B_alpha" sem="Protein_molecule">MAD3/<term id="T3" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term></term> in response to <term id="A1" sem="Organic_compound_other">inducers of <term id="T4" lex="NF-kappa_B_activity" sem="Other"><term id="T5" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity</term></term>.</sentence>
<event id="E1">
<type class="Protein_catabolism"/>
<theme idref="T2"/>
<clue>N- and C-terminal sequences control <clueType>degradation</clueType> <linkTheme>of</linkTheme> MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="A1"/>
<clue>N- and C-terminal sequences control degradation of MAD3/I kappa B alpha <linkCause>in response to</linkCause> inducers of NF-kappa B activity.</clue>
<comment>TPS: A1</comment></event>
<event id="E2">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="A20" idref1="A22"/>
<clue>N- and C-terminal sequences <clueType>control</clueType> degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.</clue>
</event>
<event id="E37">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="A21" idref1="A22"/>
<clue>N- and C-terminal sequences <clueType>control</clueType> degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The proteolytic degradation of the <term id="T6" lex="inhibitory_protein" sem="Protein_family_or_group">inhibitory protein</term> <term id="T7" lex="MAD3/I_kappa_B_alpha" sem="Protein_molecule">MAD3/<term id="T8" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term></term> in response to <term id="T9" lex="extracellular_stimulation" sem="Other">extracellular stimulation</term> is a prerequisite step in the activation of the <term id="T10" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T11" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>.</sentence>
<event KT="Other" id="E3">
<type class="Protein_catabolism"/>
<theme idref="T7"/>
<clue>The <clueType>proteolytic degradation</clueType> <linkTheme>of</linkTheme> the inhibitory protein MAD3/I kappa B alpha in response to extracellular stimulation is a prerequisite step in the activation of the transcription factor NF-kappa B.</clue>
</event>
<event KT="Fact" id="E38">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T9"/>
<clue>The proteolytic degradation of the inhibitory protein MAD3/I kappa B alpha <linkCause>in response to</linkCause> extracellular stimulation is a prerequisite step in the activation of the transcription factor NF-kappa B.</clue>
</event>
<event KT="Other" id="E4">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>The proteolytic degradation of the inhibitory protein MAD3/I kappa B alpha in response to extracellular stimulation is a prerequisite step in the <clueType>activation</clueType> <linkTheme>of</linkTheme> the transcription factor NF-kappa B.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="E3"/>
<clue>The proteolytic degradation of the inhibitory protein MAD3/I kappa B alpha in response to extracellular stimulation <clueType>is a prerequisite step</clueType> <linkTheme>in</linkTheme> the activation of the transcription factor NF-kappa B.</clue>
</event>
<sentence id="S3">Analysis of the expression of <term id="T12" lex="human_I_kappa_B_alpha_protein" sem="Protein_molecule">human <term id="T13" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> protein</term> in stable transfectants of <term id="T14" lex="mouse_70Z/3_cell" sem="Cell_cultured">mouse 70Z/3 cells</term> shows that, as for the endogenous murine protein, exogenous <term id="T15" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> is degraded in response to inducers of <term id="T16" lex="NF-kappa_B_activity" sem="Other"><term id="T17" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity</term>, such as <term id="T18" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> or <term id="T19" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term>.</sentence>
<event KT="Other" id="E6" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>Analysis of the <clueType>expression</clueType> <linkTheme>of</linkTheme> human I kappa B alpha protein <clueLoc>in stable transfectants of mouse 70Z/3 cells</clueLoc> shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity, such as phorbol myristate acetate or lipopolysaccharide.</clue>
</event>
<event KT="Analysis" id="E7">
<type class="Protein_catabolism"/>
<theme idref="T15"/>
<clue><clueKT>Analysis</clueKT> of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells <clueKT>shows</clueKT> that, as for the endogenous murine protein, exogenous I kappa B alpha is <clueType>degraded</clueType> in response to inducers of NF-kappa B activity, such as phorbol myristate acetate or lipopolysaccharide.</clue>
</event>
<event KT="Analysis" id="E39">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T18"/>
<clue><clueKT>Analysis</clueKT> of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells <clueKT>shows</clueKT> that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded <linkCause>in response to</linkCause> <corefCause>inducers of NF-kappa B activity</corefCause>, such as phorbol myristate acetate or lipopolysaccharide.</clue>
</event>
<event KT="Analysis" id="E8">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T19"/>
<clue><clueKT>Analysis</clueKT> of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells <clueKT>shows</clueKT> that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded <linkCause>in response to</linkCause> <corefCause>inducers of NF-kappa B activity</corefCause>, such as phorbol myristate acetate or lipopolysaccharide.</clue>
</event>
<sentence id="S4">In addition, pretreatment of the cells with the <term id="T20" lex="proteasome_inhibitor" sem="Other"><term id="T21" lex="proteasome" sem="Protein_complex">proteasome</term> inhibitor</term> <term id="T22" lex="N-Ac-Leu-Leu-norleucinal" sem="Organic_compound_other">N-Ac-Leu-Leu-norleucinal</term> inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the <term id="T23" lex="human_I_kappa_B_alpha_protein" sem="Protein_molecule">human <term id="T24" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> protein</term>.</sentence>
<event KT="Method" id="E9">
<type class="Physiological_process"/>
<theme idref="T14"/>
<cause idref="T22"/>
<clue>In addition, <clueType>pretreatment</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkCause>with</linkCause> the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the human I kappa B alpha protein.</clue>
</event>
<event id="E10">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="E9"/>
<clue>In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal <clueType>inhibits</clueType> <corefTheme>this ligand-induced degradation</corefTheme> and, in agreement with previous studies, stabilizes a hyperphosphorylated form of the human I kappa B alpha protein.</clue>
</event>
<event id="E11">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T23"/>
<clue>In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, stabilizes a <clueType>hyperphosphorylated</clueType> form of the human I kappa B alpha protein.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="E9"/>
<clue>In addition, pretreatment of the cells with the proteasome inhibitor N-Ac-Leu-Leu-norleucinal inhibits this ligand-induced degradation and, in agreement with previous studies, <clueType>stabilizes</clueType> a hyperphosphorylated form of the human I kappa B alpha protein.</clue>
</event>
<sentence id="S5">By expressing mutant forms of the human protein in this <term id="T25" lex="cell_line" sem="Cell_cultured">cell line</term>, we have been able to delineate the sequences responsible for both the <term id="T26" lex="ligand-induced_phosphorylation" sem="Other">ligand-induced phosphorylation</term> and the <term id="T27" lex="degradation" sem="Other">degradation</term> of <term id="T28" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>.</sentence>
<event id="E14">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T28"/>
<clue><clueExperiment>By expressing mutant forms of the human protein in this cell line</clueExperiment>, we have been able to delineate the sequences responsible for both the ligand-induced <clueType>phosphorylation</clueType> and the degradation <linkTheme>of</linkTheme> I kappa B alpha.</clue>
</event>
<event id="E15">
<type class="Protein_catabolism"/>
<theme idref="T28"/>
<clue>By expressing mutant forms of the human protein in this cell line, we have been able to delineate the sequences responsible for both the ligand-induced phosphorylation and the <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha.</clue>
</event>
<event id="E30">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T18"/>
<clue>By expressing mutant forms of the human protein in this cell line, we have been able to delineate the sequences responsible for both the <corefCause>ligand</corefCause>-<clueType>induced</clueType> phosphorylation and the degradation of I kappa B alpha.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T18"/>
<clue>By expressing mutant forms of the human protein in this cell line, we have been able to delineate the sequences responsible for both the <corefCause>ligand</corefCause>-<clueType>induced</clueType> phosphorylation and the degradation of I kappa B alpha.</clue>
</event>
<event id="E32">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T19"/>
<clue>By expressing mutant forms of the human protein in this cell line, we have been able to delineate the sequences responsible for both the <corefCause>ligand</corefCause>-<clueType>induced</clueType> phosphorylation and the degradation of I kappa B alpha.</clue>
</event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T19"/>
<clue>By expressing mutant forms of the human protein in this cell line, we have been able to delineate the sequences responsible for both the <corefCause>ligand</corefCause>-<clueType>induced</clueType> phosphorylation and the degradation of I kappa B alpha.</clue>
</event>
<sentence id="S6">Our results show that deletion of the <term id="A3" sem="Protein_domain_or_region"><term id="T29" lex="C_terminus" sem="Protein_domain_or_region">C terminus</term> of the <term id="T30" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> molecule up to <term id="T31" lex="amino_acid_279" sem="Protein_domain_or_region">amino acid 279</term></term> abolishes <term id="A4" sem="Other">constitutive</term> but not <term id="T32" lex="ligand-inducible_phosphorylation" sem="Other">ligand-inducible <term id="A5" sem="Other">phosphorylation</term></term> and inhibits <term id="T33" lex="ligand-inducible_degradation" sem="Other">ligand-inducible degradation</term>.</sentence>
<event KT="Method" id="E16">
<type class="Mutagenesis"/>
<theme idref="A3"/>
<clue>Our results show that <clueType>deletion</clueType> <linkTheme>of</linkTheme> the C terminus of the I kappa B alpha molecule up to amino acid 279 abolishes constitutive but not ligand-inducible phosphorylation and inhibits ligand-inducible degradation.</clue>
<comment>TPS: A3; ARTIFICIAL</comment></event>
<event KT="Analysis" id="E17">
<type class="Negative_regulation"/>
<theme idref="A4" idref1="A5"/>
<cause idref="E16"/>
<clue>Our results <clueKT>show</clueKT> that deletion of the C terminus of the I kappa B alpha molecule up to amino acid 279 <clueType>abolishes</clueType> constitutive but not ligand-inducible phosphorylation and inhibits ligand-inducible degradation.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E18">
<type class="Negative_regulation"/>
<theme idref="T32"/>
<cause idref="E16"/>
<clue>Our results <clueKT>show</clueKT> that deletion of the C terminus of the I kappa B alpha molecule up to amino acid 279 <clueType>abolishes</clueType> constitutive but <cluePolarity>not</cluePolarity> ligand-inducible phosphorylation and inhibits ligand-inducible degradation.</clue>
</event>
<event KT="Analysis" id="E19">
<type class="Negative_regulation"/>
<theme idref="T33"/>
<cause idref="E16"/>
<clue>Our results <clueKT>show</clueKT> that deletion of the C terminus of the I kappa B alpha molecule up to amino acid 279 abolishes constitutive but not ligand-inducible phosphorylation and <clueType>inhibits</clueType> ligand-inducible degradation.</clue>
</event>
<sentence id="S7">Further analysis reveals that the <term id="T34" lex="inducible_phosphorylation" sem="Other">inducible phosphorylation</term> of <term id="T35" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> maps to two <term id="T36" lex="serine" sem="Amino_acid_monomer">serines</term> in the <term id="T37" lex="N_terminus" sem="Protein_domain_or_region">N terminus</term> of the protein (<term id="A8" sem="Protein_domain_or_region">residues</term> <term id="A9" sem="Protein_domain_or_region">32</term> and <term id="A10" sem="Protein_domain_or_region">36</term>) and that the <term id="T38" lex="mutation" sem="Other">mutation</term> of either residue is sufficient to abolish <term id="A7" sem="Other">ligand-induced degradation</term>, whereas both <term id="T39" lex="residue" sem="Amino_acid_monomer">residues</term> must be mutated to abolish <term id="T40" lex="inducible_phosphorylation" sem="Other">inducible phosphorylation</term> of the protein.</sentence>
<event KT="Other" id="E20">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T35"/>
<clue>Further analysis reveals that the inducible <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.</clue>
</event>
<event KT="Method" id="E21">
<type class="Mutagenesis"/>
<theme idref="T36" idref1="A8" idref2="A9"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the <clueType>mutation</clueType> of <corefTheme>either residue</corefTheme> is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E27">
<type class="Mutagenesis"/>
<theme idref="T36" idref1="A8" idref2="A10"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the <clueType>mutation</clueType> of <corefTheme>either residue</corefTheme> is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Analysis" id="E22">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E21"/>
<clue>Further analysis <clueKT>reveals</clueKT> that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to <clueType>abolish</clueType> ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.</clue>
</event>
<event KT="Other" id="E23">
<type class="Protein_catabolism"/>
<theme idref="T35"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced <clueType>degradation</clueType>, whereas both residues must be mutated to abolish inducible phosphorylation <linkTheme>of</linkTheme> <corefTheme>the protein</corefTheme>.</clue>
</event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T18"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish <corefCause>ligand</corefCause>-<clueType>induced</clueType> degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.</clue>
</event>
<event KT="Other" id="E36">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T19"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish <corefCause>ligand</corefCause>-<clueType>induced</clueType> degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.</clue>
</event>
<event KT="Method" id="E24">
<type class="Mutagenesis"/>
<theme idref="A8" idref1="A9"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas <corefTheme>both residues</corefTheme> must be <clueType>mutated</clueType> to abolish inducible phosphorylation of the protein.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E28">
<type class="Mutagenesis"/>
<theme idref="A8" idref1="A10"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas <corefTheme>both residues</corefTheme> must be <clueType>mutated</clueType> to abolish inducible phosphorylation of the protein.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Analysis" id="E25">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="E24"/>
<clue>Further analysis <clueKT>reveals</clueKT> that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to <clueType>abolish</clueType> inducible phosphorylation of the protein.</clue>
</event>
<event KT="Analysis" id="E29">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E28"/>
<clue>Further analysis <clueKT>reveals</clueKT> that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to <clueType>abolish</clueType> inducible phosphorylation of the protein.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="E26"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish <clueType>inducible</clueType> phosphorylation of the protein.</clue>
</event>
<event KT="Other" id="E26">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T35"/>
<clue>Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> <corefTheme>the protein</corefTheme>.</clue>
</event>
<sentence id="S8">(ABSTRACT TRUNCATED AT 250 WORDS)</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
